Jaspreet Takhar

Jaspreet advises clients on complex issues at the intersection of healthcare, data and AI. Her practice has a particular focus on accessing and using patient data, innovative collaborations with hospitals, and the use and regulation of AI in the healthcare space across the EU and UK.

Jaspreet regularly speaks at medtech and pharma industry trade association events on issues ranging from health data and innovation to medical research.

• Advising various multinational companies on the development, regulation and supply of various AI-as-a-medical device products, including: licensing medical datasets from academic and medical institutions across the globe (for the purposes of training, testing and validating AI models); regulatory requirements under the EU AI Act, data protection laws and medical device laws; clinical research; and supply to hospitals.
• Advising sponsors and service providers on the regulatory hurdles in rolling out decentralised clinical trial elements across the globe, including remote monitoring of patients, home delivery of IMPs and deploying nurses for home visits (including data privacy issues, GCP and clinical trial regulation, and staffing models).
• Advising various multinational healthcare and life sciences companies on compliance with the EU AI Act, including identifying in-scope AI systems, economic operator role and resulting compliance obligations. This includes advising on AI chatbots for patients, AI in clinical trials, AI in apps, and various other AI use cases.
• Advising various telemedicine providers of doctor-on-demand apps on healthcare regulatory issues and data protection compliance.
• Advising on innovative collaboration agreements with NHS hospitals, including in connection with AI-related research, and setting up a new lab providing diagnostic services to other UK hospitals.
• Supporting a medtech company in contracting with NHS trusts and private hospitals across the UK for the supply of robotic surgical equipment, software and related consumables.
• Advising various multinational healthcare and life sciences companies on the use of patient data for a range of purposes, including for research and development of innovative technology, and for the provision of NHS-commissioned services.
• Advising various multinational companies on developing responsible AI governance frameworks compatible with international regulation and best practices, including producing policies, risk assessment processes and documentation, governance forums, updating contracting terms with third parties, and providing training.
• Advising on all aspects of Code compliance for promotional activities (including the ABPI Code and ABHI Code), including drafting policies and SOPs, advising on specific promotional activities (such as disease awareness campaigns), and responding to PMCPA complaints and adjudication decisions.